Abstract
Purpose
Advancing age represents the strongest risk factor for Alzheimer’s disease (AD), and the identification of biomarkers able to define what characterizes physiological aging from AD may represent a potential starting point for novel preventive strategies. Among these biomarkers, telomeres seem to be a promising target. Interestingly, high intake of carotenoid-rich food may play a role in protecting telomeres by oxidative stress reduction. Accordingly, low plasma β-carotene concentrations have been found in AD subjects when compared with cognitively healthy subjects. In this study, we aim at investigating the hypothesis that low β-carotene might be associated with markers of accelerated cellular aging, including leucocyte telomere length (LTL) and peripheral mononuclear cell (PBMC) telomerase activity in a cohort of old age subjects.
Methods
The study was conducted in 68 old age subjects, 37 AD, and 31 age-matched healthy controls. In all subjects, β-carotene plasma level, LTL and peripheral telomerase activity were measured.
Results
In all populations, β-carotene significantly and positively (r = 0.320, p = 0.008) correlated with telomerase activity, independent of gender. A model having telomerase activity levels as the dependent variable, and age, gender, smoking habit, and β-carotene as independent variables, confirmed that β-carotene was independently associated with telomerase activity (β = 0.319, p = 0.012). Subjects affected by AD had significantly lower plasmatic levels of β-carotene (448 ± 66 mg/ml vs 497 ± 59 mg/ml, p = 0.001) and LTL (0.53 ± 0.25 vs 0.69 ± 0.29; p = 0.009) as compared with healthy controls. Β-carotene plasma level was associated with AD diagnosis (OR 0.988; IC95% 0.978–0.997; p = 0.013) independently of age, gender, smoking habit, ApoE genotype, and LTL.
Conclusion
Our data show that β-carotene may modulate telomerase activity in old age. Moreover, lower plasma β-carotene levels, correlating with peripheral telomerase activity, are associated with AD diagnosis independent of multiple covariates.
Similar content being viewed by others
References
López-Otín C, Blasco MA, Partridge L et al (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
Flanary BE, Sammons NW, Nguyen C et al (2007) Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res 10:61–74. https://doi.org/10.1089/rej.2006.9096
Jaskelioff M, Muller FL, Paik JH et al (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102–107. https://doi.org/10.1038/nature09603
Boccardi V, Pelini L, Ercolani S et al (2015) From cellular senescence to Alzheimer’s disease: the role of telomere shortening. Ageing Res Rev 22:1–8. https://doi.org/10.1016/j.arr.2015.04.003
Saretzki G, Von Zglinicki T (2002) Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 959:24–29. https://doi.org/10.1111/j.1749-6632.2002.tb02079.x
Mecocci P, Boccardi V, Cecchetti R et al (2018) A long journey into aging, brain aging, and Alzheimer’s disease following the oxidative stress tracks. J Alzheimers Dis 62:1319–1335. https://doi.org/10.3233/JAD-170732
Morales I, Guzman-Martinez L, Cerda-Troncoso C et al (2014) Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112. https://doi.org/10.3389/fncel.2014.00112
Matthews C, Gorenne I, Scott S et al (2006) Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 99:156–164. https://doi.org/10.1161/01.RES.0000233315.38086.bc
Boccardi V, Paolisso G (2014) Telomerase activation: a potential key modulator for human healthspan and longevity. Ageing Res Rev 15:1–5. https://doi.org/10.1016/j.arr.2013.12.006
Tomás-Loba A, Flores I, Fernández-Marcos PJ et al (2008) Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 135:609–622. https://doi.org/10.1016/j.cell.2008.09.034
Bernardes De Jesus B, Blasco MA (2011) Aging by telomere loss can be reversed. Cell Stem Cell 8:3–4. https://doi.org/10.1016/j.stem.2010.12.013
Weng NP, Palmer LD, Levine BL et al (1997) Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 160:43–54. https://doi.org/10.1111/j.1600-065X.1997.tb01026.x
Furumoto K, Inoue E, Nagao N et al (1998) Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci 63:935–948. https://doi.org/10.1016/S0024-3205(98)00351-8
Johnson EJ (2002) The role of carotenoids in human health. Nutr Clin Care 5:56–65. https://doi.org/10.1046/j.1523-5408.2002.00004.x
Cooperstone JL, Schwartz SJ (2016) Recent insights into health benefits of carotenoids. Handb Nat Pigment Food Beverages Ind Appl Improv Food Color. https://doi.org/10.1016/B978-0-08-100371-8.00020-8
Li F-J, Shen L (2012) Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer’s disease: a meta-analysis. J Alzheimer’s Dis 31:253–258. https://doi.org/10.3233/JAD-2012-120349
Stuerenburg HJ, Ganzer S, Müller-Thomsen T (2005) Plasma betacarotene in Alzheimer’s disease. Association with cerebrospinal fluid beta-amyloid 1–40, (Abeta40), beta-amyloid 1–42 (Abeta42) and total Tau. Neuroendocrinol Lett 26:696–698
Rinaldi P, Polidori MC, Metastasio A et al (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 24:915–919. https://doi.org/10.1016/S0197-4580(03)00031-9
de Oliveira BF, Veloso CA, Nogueira-Machado JA et al (2012) Ascorbic acid, alpha-tocopherol, and beta-carotene reduce oxidative stress and proinflammatory cytokines in mononuclear cells of Alzheimer’s disease patients. Nutr Neurosci 15:244–251. https://doi.org/10.1179/1476830512Y.0000000019
Min KB, Min JY (2017) Association between leukocyte telomere length and serum carotenoid in US adults. Eur J Nutr 56:1045–1052. https://doi.org/10.1007/s00394-016-1152-x
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
Tabert MH, Albert SM, Borukhova-Milov L et al (2002) Functional deficits in patients with mild cognitive impairment: Prediction of AD. Neurology 58:758–764. https://doi.org/10.1212/WNL.58.5.758
Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA J Am Med Assoc 185:914–919. https://doi.org/10.1001/jama.1963.03060120024016
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186. https://doi.org/10.1093/geront/9.3_Part_1.179
Mungas D, Marshall SC, Weldon M et al (1996) Age and education correction of mini-mental state examination for english- and spanish-speaking elderly. Neurology 46:700–706. https://doi.org/10.1212/WNL.46.3.700
Dubois B, Epelbaum S, Santos A et al (2013) Alzheimer disease: from biomarkers to diagnosis. Rev Neurol 169:744–751. https://doi.org/10.1016/j.neurol.2013.07.016
Tedone E, Arosio B, Gussago C et al (2014) Leukocyte telomere length and prevalence of age-related diseases in semisupercentenarians, centenarians and centenarians’ offspring. Exp Gerontol 58:90–95. https://doi.org/10.1016/j.exger.2014.06.018
Tedone E, Arosio B, Colombo F et al (2015) Leukocyte telomere length in Alzheimer’s disease patients with a different rate of progression. J Alzheimer’s Dis 46:761–769. https://doi.org/10.3233/JAD-142808
Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:47e–47. https://doi.org/10.1093/nar/30.10.e47
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. https://doi.org/10.1093/nar/16.3.1215
Arosio B, Trabattoni D, Galimberti L et al (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease. Neurobiol Aging 25:1009–1015. https://doi.org/10.1016/j.neurobiolaging.2003.10.009
Cooper DA (2004) Carotenoids in health and disease: recent scientific evaluations, research recommendations and the consumer. J Nutr 134:221S–224S. https://doi.org/10.1093/jn/134.1.221S
Krinsky NI, Johnson EJ (2005) Carotenoid actions and their relation to health and disease. Mol Aspects Med 26:459–516. https://doi.org/10.1016/j.mam.2005.10.001
Min J, Min K (2014) serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer’s disease mortality in older adults. Dement Geriatr Cogn Disord 37:246–256. https://doi.org/10.1159/000356486
Jacobs EG, Epel ES, Lin J et al (2014) Relationship between leukocyte telomere length, telomerase activity, and hippocampal volume in early aging. JAMA Neurol 71:921–923. https://doi.org/10.1001/jamaneurol.2014.870
Epel ES, Blackburn EH, Lin J et al (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci 101:17312–17315. https://doi.org/10.1073/pnas.0407162101
Simon NM, Smoller JW, McNamara KL et al (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60:432–435. https://doi.org/10.1016/j.biopsych.2006.02.004
de Jesus BB, Blasco MA (2012) Potential of telomerase activation in extending health span and longevity. Curr Opin Cell Biol 24:739–743. https://doi.org/10.1016/j.ceb.2012.09.004
Bernardes de Jesus B, Vera E, Schneeberger K et al (2012) Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 4:691–704. https://doi.org/10.1002/emmm.201200245
Jevtic S, Sengar AS, Salter MW, McLaurin J (2017) The role of the immune system in Alzheimer disease: etiology and treatment. Ageing Res Rev 40:84–94. https://doi.org/10.1016/j.arr.2017.08.005
Devore EE, Kang JH, Stampfer MJ, Grodstein F (2013) The association of antioxidants and cognition in the Nurses’ Health Study. Am J Epidemiol 177:33–41. https://doi.org/10.1093/aje/kws202
Wengreen HJ, Munger RG, Corcoran CD et al (2007) Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging 11:230–237
Engelhart MJ, Geerlings MI, Ruitenberg A et al (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223–3229. https://doi.org/10.1001/jama.287.24.3223
Hu P, Bretsky P, Crimmins EM et al (2006) Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 Alleles: MacArthur studies of successful aging. Journals Gerontol Ser A Biol Sci Med Sci 61:616–620. https://doi.org/10.1093/gerona/61.6.616
Grodstein F, Kang JH, Glynn RJ et al (2007) A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians’ Health Study II. Arch Intern Med 167:2184–2190. https://doi.org/10.1001/archinte.167.20.2184
Kang JH, Cook NR, Manson JE et al, Vitamin C (2009) Vitamin E. Beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the women’s antioxidant and cardiovascular study. Circulation 119:2772–2780. https://doi.org/10.1161/CIRCULATIONAHA.108.816900
Su Q, Rowley KG, Itsiopoulos C, O’Dea K (2002) Identification and quantification of major carotenoids in selected components of the Mediterranean diet: green leafy vegetables, figs and olive oil. Eur J Clin Nutr 56:1149–1154. https://doi.org/10.1038/sj.ejcn.1601472
Boccardi V, Esposito A, Rizzo MR et al (2013) Mediterranean diet, telomere maintenance and health status among elderly. PLoS One 8:e62781. https://doi.org/10.1371/journal.pone.0062781
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Boccardi, V., Arosio, B., Cari, L. et al. Beta-carotene, telomerase activity and Alzheimer’s disease in old age subjects. Eur J Nutr 59, 119–126 (2020). https://doi.org/10.1007/s00394-019-01892-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-019-01892-y